Cilostazol and Aspirin in Stroke and TIA

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 378 participants.

Also called NCT06522113

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 378 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06522113
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06522113. Randomized; no masking; primary purpose treatment. Start 2019-07-18 (actual); primary completion 2022-10-17 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cilostazol and Aspirin in Stroke and TIA
Intervention (Drug)
Cilostazol
Intervention (Drug)
Clopidogrel
Lead sponsor
Incheon St.Mary's Hospital (class: other)

Record details

Record id
cardio:ct-nct06522113
Content hash
b32a6cef74177365ae85df06a41201fe5f2a3898c7978a5361b27156f385519b